162 related articles for article (PubMed ID: 24211314)
1. Combined inhibition of Na⁺ and Ca²⁺ channels: a novel paradigm for the treatment of incessant ventricular arrhythmias in Andersen-Tawil syndrome.
Janson CM; Poelzing S; Shah MJ
Heart Rhythm; 2014 Feb; 11(2):318-20. PubMed ID: 24211314
[No Abstract] [Full Text] [Related]
2. Inhibition of Na+ channels ameliorates arrhythmias in a drug-induced model of Andersen-Tawil syndrome.
Radwański PB; Greer-Short A; Poelzing S
Heart Rhythm; 2013 Feb; 10(2):255-63. PubMed ID: 23041575
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
[TBL] [Abstract][Full Text] [Related]
4. Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.
Bökenkamp R; Wilde AA; Schalij MJ; Blom NA
Heart Rhythm; 2007 Apr; 4(4):508-11. PubMed ID: 17399642
[No Abstract] [Full Text] [Related]
5. Cytosolic calcium accumulation and delayed repolarization associated with ventricular arrhythmias in a guinea pig model of Andersen-Tawil syndrome.
Radwański PB; Veeraraghavan R; Poelzing S
Heart Rhythm; 2010 Oct; 7(10):1428-1435.e1. PubMed ID: 20380896
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of the intravenous flecainide challenge test before oral flecainide treatment in a patient with Andersen-Tawil syndrome.
Sato A; Takano T; Chinushi M; Minamino T
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31311787
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of flecainide in bidirectional ventricular tachycardia and tachycardia-induced cardiomyopathy with Andersen-Tawil syndrome.
Ünal Yüksekgönül A; Azak E; Akalın A; Ertuğrul İ; Kılıç E; Utine GE; Karagöz T
Eur J Med Genet; 2022 Jun; 65(6):104499. PubMed ID: 35429663
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic characteristics of an Andersen syndrome patient with KCNJ2 mutation.
Nagase S; Kusano KF; Yoshida M; Ohe T
Heart Rhythm; 2007 Apr; 4(4):512-5. PubMed ID: 17399643
[TBL] [Abstract][Full Text] [Related]
9. Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.
Mazzanti A; Guz D; Trancuccio A; Pagan E; Kukavica D; Chargeishvili T; Olivetti N; Biernacka EK; Sacilotto L; Sarquella-Brugada G; Campuzano O; Nof E; Anastasakis A; Sansone VA; Jimenez-Jaimez J; Cruz F; Sánchez-Quiñones J; Hernandez-Afonso J; Fuentes ME; Średniawa B; Garoufi A; Andršová I; Izquierdo M; Marinov R; Danon A; Expósito-García V; Garcia-Fernandez A; Muñoz-Esparza C; Ortíz M; Zienciuk-Krajka A; Tavazzani E; Monteforte N; Bloise R; Marino M; Memmi M; Napolitano C; Zorio E; Monserrat L; Bagnardi V; Priori SG
J Am Coll Cardiol; 2020 Apr; 75(15):1772-1784. PubMed ID: 32299589
[TBL] [Abstract][Full Text] [Related]
10. Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
Ergül Y; Özgür S; Onan SH; Tuzcu V
Turk Kardiyol Dern Ars; 2018 Dec; 46(8):718-722. PubMed ID: 30516532
[TBL] [Abstract][Full Text] [Related]
11. Andersen-Tawil syndrome associated with aborted sudden cardiac death: atrial pacing was effective for ventricular arrhythmias.
Kuramoto Y; Furukawa Y; Yamada T; Okuyama Y; Fukunami M
Am J Med Sci; 2012 Sep; 344(3):248-50. PubMed ID: 22739561
[TBL] [Abstract][Full Text] [Related]
12. Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome.
Pellizzón OA; Kalaizich L; Ptácek LJ; Tristani-Firouzi M; Gonzalez MD
J Cardiovasc Electrophysiol; 2008 Jan; 19(1):95-7. PubMed ID: 17655675
[TBL] [Abstract][Full Text] [Related]
13. Failure of radiofrequency catheter ablation and success of flecainide to suppress premature ventricular contractions in Andersen-Tawil syndrome: A case report.
Yilmaz S; Kanat S
J Electrocardiol; 2021; 68():37-40. PubMed ID: 34311212
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic management of ventricular arrhythmias in Andersen-Tawil syndrome.
Maffè S; Paffoni P; Bergamasco L; Dellavesa P; Zenone F; Baduena L; Franchetti Pardo N; Careri G; Facchini E; Sansone V; Parravicini U
J Electrocardiol; 2020; 58():37-42. PubMed ID: 31710873
[TBL] [Abstract][Full Text] [Related]
15. Imipramine for incessant ventricular arrhythmias in 2 unrelated patients with Andersen-Tawil syndrome.
Bigelow AM; Khalifa MM; Clark JM
Heart Rhythm; 2015 Jul; 12(7):1654-7. PubMed ID: 25814423
[No Abstract] [Full Text] [Related]
16. NCX is an important determinant for premature ventricular activity in a drug-induced model of Andersen-Tawil syndrome.
Radwański PB; Poelzing S
Cardiovasc Res; 2011 Oct; 92(1):57-66. PubMed ID: 21697145
[TBL] [Abstract][Full Text] [Related]
17. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of U wave and polymorphic ventricular tachycardia in a canine tissue model of Andersen-Tawil syndrome.
Morita H; Zipes DP; Morita ST; Wu J
Cardiovasc Res; 2007 Aug; 75(3):510-8. PubMed ID: 17531215
[TBL] [Abstract][Full Text] [Related]
19. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature.
Pott C; Dechering DG; Reinke F; Muszynski A; Zellerhoff S; Bittner A; Köbe J; Wasmer K; Schulze-Bahr E; Mönnig G; Kotthoff S; Eckardt L
Europace; 2011 Jun; 13(6):897-901. PubMed ID: 21292648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
